BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 14599923)

  • 1. Molecular therapy and prevention of hepatocellular carcinoma.
    Blum HE
    Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):11-22. PubMed ID: 14599923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular targets for prevention of hepatocellular carcinoma.
    Blum HE
    Dig Dis; 2002; 20(1):81-90. PubMed ID: 12145424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatocellular carcinoma. Pathogenesis and multicentricity].
    Blum HE; Hopt UT
    Chirurg; 2003 Aug; 74(8):709-16. PubMed ID: 12928791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
    Marotta F; Vangieri B; Cecere A; Gattoni A
    Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hepatocellular carcinoma.
    Blum HE
    Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):129-45. PubMed ID: 15757809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in prevention and diagnosis of hepatocellular carcinoma.
    Spangenberg HC; Thimme R; Blum HE
    Expert Rev Gastroenterol Hepatol; 2008 Jun; 2(3):425-33. PubMed ID: 19072390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention.
    Anwar WA; Khaled HM; Amra HA; El-Nezami H; Loffredo CA
    Mutat Res; 2008; 659(1-2):176-84. PubMed ID: 18346933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatocellular carcinoma: molecular biology aspects].
    Blum HE
    Zentralbl Chir; 1994; 119(11):759-63. PubMed ID: 7846955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathogenesis of hepatocellular carcinoma.
    McKillop IH; Moran DM; Jin X; Koniaris LG
    J Surg Res; 2006 Nov; 136(1):125-35. PubMed ID: 17023002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis].
    Schott E; Bergk A; Berg T
    Z Gastroenterol; 2008 Jan; 46(1):69-80. PubMed ID: 18188819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA interference-mediated prevention and therapy for hepatocellular carcinoma.
    Romano PR; McCallus DE; Pachuk CJ
    Oncogene; 2006 Jun; 25(27):3857-65. PubMed ID: 16799627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
    Xue KX
    Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central genetic alterations common to all HCV-positive, HBV-positive and non-B, non-C hepatocellular carcinoma: a new approach to identify novel tumor markers.
    Kurokawa Y; Honma K; Takemasa I; Nakamori S; Kita-Matsuo H; Motoori M; Nagano H; Dono K; Ochiya T; Monden M; Kato K
    Int J Oncol; 2006 Feb; 28(2):383-91. PubMed ID: 16391793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer.
    Hussain SP; Schwank J; Staib F; Wang XW; Harris CC
    Oncogene; 2007 Apr; 26(15):2166-76. PubMed ID: 17401425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New therapies for hepatocellular carcinoma.
    Avila MA; Berasain C; Sangro B; Prieto J
    Oncogene; 2006 Jun; 25(27):3866-84. PubMed ID: 16799628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic epidemiological study on single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic HBV infection].
    Kim YJ; Lee HS
    Korean J Hepatol; 2009 Mar; 15(1):7-14. PubMed ID: 19346781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of hepatocellular carcinoma.
    Colombo M; Donato MF
    Semin Liver Dis; 2005; 25(2):155-61. PubMed ID: 15918144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy for HCV/HBV-induced hepatocellular carcinoma.
    Smerdou C; Menne S; Hernandez-Alcoceba R; Gonzalez-Aseguinolaza G
    Curr Opin Investig Drugs; 2010 Dec; 11(12):1368-77. PubMed ID: 21154119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden.
    Nguyen VT; Law MG; Dore GJ
    J Viral Hepat; 2009 Jul; 16(7):453-63. PubMed ID: 19302335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma.
    Sherman M
    Gastroenterologist; 1995 Mar; 3(1):55-66. PubMed ID: 7538016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.